SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950142-24-000377
Filing Date
2024-02-13
Accepted
2024-02-13 10:17:30
Documents
1
Group Members
GA RP HOLDING, L.P.GA RP HOLDING, LTD.GAP (BERMUDA) L.P.GAP COINVESTMENTS CDA, L.P.GAP COINVESTMENTS III, LLCGAP COINVESTMENTS IV, LLCGAP COINVESTMENTS V, LLCGENERAL ATLANTIC (LUX) S.A.R.L.GENERAL ATLANTIC (RP) COLLECTIONS, LLCGENERAL ATLANTIC (SPV) GP, L

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 eh240447579_13ga2-rprx.htm SC 13G/A 331307
  Complete submission text file 0000950142-24-000377.txt   334068
Mailing Address 55 EAST 52ND STREET 33RD FLOOR NEW YORK NY 10055
Business Address 55 EAST 52ND STREET 33RD FLOOR NEW YORK NY 10055 212 715 4000
GENERAL ATLANTIC, L.P. (Filed by) CIK: 0001017645 (see all company filings)

IRS No.: 133503735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Subject) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91540 | Film No.: 24623184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)